发明名称 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
摘要 A method of treating a mammal comprises administering to a mammal an effective amount to provide a desired therapeutic effect in the mammal of a compound selected from the group consisting of those having the formula: <IMAGE> and pharmaceutically acceptable acid addition salts thereof and mixtures thereof, wherein R1 and R2 each is selected from the group consisting of alkyl radicals containing 1 to 4 carbon atoms and alkoxy radicals containing 1 to 4 carbon atoms, the 2-imidazolin-2-ylamino group may be in any of the 5-, 6-, 7- or 8- positions of the quinoxaline nucleus, and R3, R4 and R5 each is located in one of the remaining 5-, 6-, 7- or 8- positions of the quinoxaline nucleus and is independently selected from the group consisting of Cl, Br, H and alkyl radicals containing 1 to 3 carbon atoms wherein the desired therapeutic effect is an increase in renal fluid flow.
申请公布号 US5703077(A) 申请公布日期 1997.12.30
申请号 US19960693745 申请日期 1996.08.07
申请人 ALLERGAN 发明人 BURKE, JAMES A.;GARST, MICHAEL E.;WHEELER, LARRY A.
分类号 C07D401/12;A61K31/495;A61K31/498;A61P1/12;A61P1/14;A61P9/00;A61P9/10;A61P9/12;A61P11/02;A61P13/02;A61P13/12;A61P15/00;A61P23/00;A61P23/02;A61P25/00;A61P25/02;A61P25/04;A61P27/16;A61P29/00;C07D403/12;(IPC1-7):A61K31/495 主分类号 C07D401/12
代理机构 代理人
主权项
地址